Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director of IT Operations will lead enterprise IT operations, service delivery, and operational strategy as Revolution Medicines scales globally and prepares for commercialization. This leader will oversee enterprise platforms, infrastructure, and IT service management while driving operational excellence through automation, AI-enhanced operations, standardized processes, and resilient enterprise services. Reporting to the Executive Director of IT, this role requires a strategic, hands-on leader capable of scaling global IT operations while building a high-performing team aligned to the company’s next stage of growth.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director